Incorporated in 1991 and situated in Ningbo, China, Ningbo Smart Pharmaceutical Co., Ltd ("Smart Pharm") resides in a 20,000 square meter land easily accessible by multiple forms of transit.
Smart Pharm is a modern and integrated pharmaceutical manufacturing company engaged in research, production, and sales of various APIs and their intermediates. Some of the company's primary products include Mefenamic Acid, Diclofenac Sodium, Methocarbamol, Guaifenesin,Parecoxib Sodium，Mequitazine, Mephenoxalone, and Indolinone.
Smart Pharm focuses on innovation. We adhere to strict hiring practices and target highly-trained professionals who we continue to train and develop throughout their careers. The company's Research and Development teams continuously work on developing new APIs and OEM Chemical Intermediates.
Smart Pharm is proud of its quality management system which oversees the overall production and quality management in accordance with the Chinese GMP and ICH Q7A regulations. By complying with the relevant regulations and maintaining our own strict internal practices we have, to date:
* obtained CEP and European GMP Certifications for Diclofenac Sodium;
* obtained Chinese GMP approval for Mefenamic Acid, Diclofenac Sodium, Methocarbamol, Guaifenesin and Parecoxib Sodium.
Our market presence has spread across multiple countries and jurisdictions including, but not limited to, Europe, India, Indonesia, Japan, Korean, Pakistan, and Taiwan. Over our three decades of work in this field we have developed long-standing relationships and close ties with several multinational companies worldwide.
